Search Media Items

The NIH Planning Grant Program (R34) provides support for the initial development of a clinical trial or research project. This program may support:.

Learn how to address rigor and reproducibility in your grant application and discover what reviewers are looking for as they evaluate the application for scientific merit.

Note to Reviewers: These documents are provided as general reviewer orientation to NIH peer review. For meeting specific information, please rely on the documents and links provided by your SRO.

The PHS Human Subjects and Clinical Trials Information Form is used to collect information on:.

This page provides information on the NIH Next Generation Researchers Initiative policies that support early-stage investigators (ESIs).

The core values of peer review drive the NIH to seek the highest level of ethical standards, and form the foundation for the laws, regulations, and policies that govern the NIH peer review process. The NIH dual peer review system is mandated by statute in accordance with section 492 of the Public Health Service Act and federal regulations governing "Scientific Peer Review of Research Grant Applications and Research and Development Contract Projects". NIH policy is intended to promote a process whereby grant applications submitted to the NIH are evaluated on the basis of a process that strives to be fair, equitable, timely, and free of bias.

A research study in which one or more human subjects are prospectively assigned prospectively assigned The term "prospectively assigned" refers to a pre-defined process (e.g., randomization) specified in an approved protocol that stipulates the assignment of research subjects (individually or in clusters) to one or more arms (e.

The Application Submission System & Interface for Submission Tracking (ASSIST) system is used to prepare and submit grant applications electronically to NIH and other Public Health Service agencies. Check out this step by step guide for using ASSIST.